NCT01129713View on ClinicalTrials.gov

Comparison of Nexium Versus Secretol in the Healing and Controlling of Symptoms in GERD Patients With Severe EE.

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Gastroesophageal Reflux Disease (GERD)HeartburnIndigestion
Interventions
DRUG

Secretol

Comparing 80/80 once daily to Nexium once daily in healing erosive esophagitis.

DRUG

Nexium

Comparing 40 mg Nexium once daily to 80/80 Secretol once daily in healing erosive esophagitis.

Trial Locations (1)

85723

RECRUITING

Southern Arizona Veterans Health Care System, Tucson

Sponsors
All Listed Sponsors
collaborator

Southern Arizona VA Health Care System

FED

lead

Effexus Pharmaceutical

INDUSTRY

NCT01129713 - Comparison of Nexium Versus Secretol in the Healing and Controlling of Symptoms in GERD Patients With Severe EE. | Biotech Hunter | Biotech Hunter